{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9Y6H8",
      "entity_text" : "Cx46",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:446013",
      "entity_text" : "FDA",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Several of the top hits were screened at concentrations between 0.1 and 10 mM, and we found that the FDA approved anti-mycobacterial drug clofazimine inhibited Cx46 GJIC at the lowest concentrations compared to the other hits (XREF_FIG), with little effect on Cx46 hemichannel activity, as determined by the amount of calcein lost from sparsely plated cells (XREF_FIG).",
  "reading_complete" : "2020-08-08T12:22:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T12:19:35Z",
  "trigger" : "inhibited",
  "evidence" : [ "FDA-approved anti-mycobacterial drug clofazimine inhibited Cx46" ],
  "pmc_id" : "6497083",
  "score" : 0
}